Screening for Barrett's Esophagus Progressors with Multimodality Tethered Capsule Image-Guided Biopsy
使用多模态系留胶囊图像引导活检筛查巴雷特食管进展者
基本信息
- 批准号:10591985
- 负责人:
- 金额:$ 64.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAneuploidyAreaBackBarrett EsophagusBiological MarkersBiopsyCellsClinicalClinical ResearchColorColumnar CellConscious SedationCyclin ADataDeglutitionDevicesDiagnosisDisease SurveillanceDysplasiaEarly InterventionEndoscopic BiopsyEndoscopyEpithelialEsophageal AdenocarcinomaEsophageal Intraepithelial NeoplasiaEsophageal TissueEsophagusFiberFluorescenceForcepFreezingFutureGastroesophageal reflux diseaseGeneral PopulationGenesGrantHealthcare SystemsHigh PrevalenceHistologicHistologyImageImage AnalysisImage Guided BiopsyImaging technologyIncidenceInterceptInterventionLaboratoriesLightLight-Scattering SpectroscopyLocationMalignant NeoplasmsMalignant neoplasm of esophagusMetabolicMetaplasiaMetaplastic CellMethodsMethylationMicroscopyModificationMolecularMolecular AbnormalityMolecular GeneticsMutationNursesOptical Coherence TomographyOpticsOxidation-ReductionPatientsPersonsPopulationProxyResearchRiskSamplingScreening procedureSedation procedureSiteSpectrum AnalysisSystemTP53 geneTechniquesTechnologyTestingTimeTissue SampleTissuesValidationWorkbasebiomarker discoverycapsulecohortcostdeep learningdeep learning algorithmdesignfollow-uphigh riskimage guidedimaging biomarkerimprovedin vivoinnovationmicroendoscopymicroscopic imagingmortalitymultimodalitynoveloverexpressionpopulation basedpredictive markerprimary care settingprogression markerreal-time imagesscreeningspectrographstandard of caretargeted imagingtissue biomarkers
项目摘要
Esophageal adenocarcinoma (EAC) is a deadly cancer that is preceded by a metaplastic change called Barrett's
esophagus (BE). It has long been thought that endoscopic screening for BE followed by endoscopic surveillance
can significantly decrease the mortality of EAC. This unfortunately has not borne out as the cost and
inconvenience of conscious sedation prohibits endoscopy from being used as a population-based screening tool.
BE screening may become possible in the future, owing to innovative swallowable tethered capsule
endomicroscopes or cell sampling devices that can detect BE without requiring sedation. Yet, even if these
capsules were to identify the large number of people in the US who have BE (~15M), endoscopic surveillance
of this group would be prohibitively expensive. If we could use tissue biomarkers to identify the 5% of those with
BE who will develop EAC in their lifetimes, then endoscopic intervention could be given to those who really need
it, and those with low-risk BE would not require further follow up.
Recognition of this need has motivated the field to identify BE progression biomarkers derived from esophageal
tissue samples obtained by autofluorescence/reflectance-targeted endoscopy. This research has identified
biomarkers such as aneuploidy and aberrant p53/cyclin A expression as strong predictors of BE progression.
Unfortunately, the only way to target and obtain these tissues today is through sedated endoscopy. With the
modifications proposed here, a new BE screening technology that we have developed called optical coherence
tomography (OCT) tethered capsule endomicroscopy (TCE), could enable targeted biopsy without sedation.
OCT-TCE obtains 3D microscopic images of the entire esophagus in unsedated subjects, accurately identifies
BE, and has been successfully used by nurses and technicians in primary care settings. Here, we propose to
advance OCT-TCE for targeted biopsy by adding autofluorescence and reflectance spectral imaging technology
that can help identify tissue enriched in molecular alterations associated with BE progression risk. The new
capsule will also have a cryobiopsy mechanism for acquiring targeted tissue samples under real time image
guidance. In Aim 1 of this proposal, we will develop this multimodality TCE with biopsy (MM-TCEB) device and
show that it works as intended in a study of 20 BE patients. Then, we will conduct a clinical study in 100
unsedated BE patients to demonstrate that MM-TCEB collects tissue and identifies BE progression biomarkers
as well as sedated endoscopy. In Aim 3, we will develop image analysis and deep learning algorithms to mine
the Aim 2 data, uncovering new relationships between OCT, autofluorescence, and reflectance spectroscopy
and tissue-derived BE progression biomarkers. By acquiring targeted biopsies using a swallowable tethered
capsule in unsedated subjects, MM-TCEB can become a powerful technique for obtaining esophageal tissue
samples for BE progression biomarker discovery, validation, and ultimately population-based screening.
食管腺癌 (EAC) 是一种致命的癌症,发生前会发生称为巴雷特氏癌的化生性改变
食道(BE)。长期以来,人们一直认为内镜筛查 BE 后进行内镜监测
可以显着降低EAC的死亡率。不幸的是,这并没有得到证实,因为成本和
清醒镇静的不便阻碍了内窥镜检查作为基于人群的筛查工具。
由于创新的可吞咽系留胶囊,BE 筛查在未来可能成为可能
无需镇静即可检测 BE 的内窥镜或细胞采样装置。然而,即使这些
胶囊旨在识别美国大量患有 BE (~15M) 的人,内窥镜监测
这个群体的费用将非常昂贵。如果我们可以使用组织生物标志物来识别 5% 的患者
BE那些一生中会发生EAC的人,那么可以对那些真正需要的人进行内镜干预
那些具有低风险 BE 的患者不需要进一步随访。
对这一需求的认识促使该领域识别源自食管的 BE 进展生物标志物
通过自发荧光/反射目标内窥镜检查获得的组织样本。这项研究已确定
非整倍体和异常 p53/细胞周期蛋白 A 表达等生物标志物是 BE 进展的强预测因子。
不幸的是,当今瞄准和获取这些组织的唯一方法是通过镇静内窥镜检查。随着
这里提出的修改是我们开发的一种新的 BE 筛选技术,称为光学相干性
断层扫描(OCT)系留胶囊内显微镜(TCE)可以在不使用镇静剂的情况下进行靶向活检。
OCT-TCE 获得未镇静受试者整个食道的 3D 显微图像,准确识别
BE,并已被初级保健机构的护士和技术人员成功使用。在此,我们建议
通过添加自发荧光和反射光谱成像技术,推进用于靶向活检的 OCT-TCE
这可以帮助识别富含与 BE 进展风险相关的分子改变的组织。新的
胶囊还将具有冷冻活检机制,用于在实时图像下获取目标组织样本
指导。在本提案的目标 1 中,我们将开发这种带有活检的多模态 TCE (MM-TCEB) 设备和
一项对 20 名 BE 患者进行的研究显示,它的作用符合预期。然后,我们将进行100年的临床研究
未镇静的 BE 患者证明 MM-TCEB 收集组织并识别 BE 进展生物标志物
以及镇静内窥镜检查。在目标3中,我们将开发图像分析和深度学习算法来挖掘
Aim 2 数据,揭示 OCT、自发荧光和反射光谱之间的新关系
和组织来源的 BE 进展生物标志物。通过使用可吞咽式系绳获取目标活组织检查
在未镇静的受试者中使用胶囊,MM-TCEB 可以成为获取食管组织的强大技术
用于 BE 进展生物标志物发现、验证和最终基于人群的筛查的样本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guillermo J Tearney其他文献
Assessment of Lipid Rich Plaque Containing Necrotic Core Using a Multi-Modality Near-Infrared Autofluorescence and Optical Coherence Tomography Imaging System
使用多模态近红外自发荧光和光学相干断层扫描成像系统评估含有坏死核心的富脂斑块
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Kohei Watanabe;Joseph A Gardecki;Kensuke Nishimiya;Zhonglie Piao;Daisuke Yamada;Guillermo J Tearney - 通讯作者:
Guillermo J Tearney
Histopathology underlying environmental enteric dysfunction in a cohort study of undernourished children in Bangladesh, Pakistan, and Zambia compared with United States children
孟加拉国、巴基斯坦和赞比亚营养不良儿童队列研究与美国儿童相比的环境性肠功能障碍的组织病理学基础
- DOI:
10.1016/j.ajcnut.2024.02.028 - 发表时间:
2024-09-01 - 期刊:
- 影响因子:6.900
- 作者:
Paul Kelly;Kelley VanBuskirk;David Coomes;Samer Mouksassi;Gerald Smith;Zehra Jamil;Md Shabab Hossain;Sana Syed;Chelsea Marie;Phillip I Tarr;Peter B Sullivan;William A Petri;Donna M Denno;Tahmeed Ahmed;Mustafa Mahfuz;S Asad Ali;Sean R Moore;I Malick Ndao;Guillermo J Tearney;Ömer H Yilmaz;Kanekwa Zyambo - 通讯作者:
Kanekwa Zyambo
Technology Insight: optical coherence tomography—current status and future development
技术洞察:光学相干断层扫描——现状与未来发展
- DOI:
10.1038/ncpcardio0482 - 发表时间:
2006-03-01 - 期刊:
- 影响因子:44.200
- 作者:
Adrian F Low;Guillermo J Tearney;Brett E Bouma;Ik-Kyung Jang - 通讯作者:
Ik-Kyung Jang
Guillermo J Tearney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guillermo J Tearney', 18)}}的其他基金
Screening for Barrett's Esophagus Progressors with Multimodality Tethered Capsule Image-Guided Biopsy
使用多模态系留胶囊图像引导活检筛查巴雷特食管进展者
- 批准号:
10708177 - 财政年份:2022
- 资助金额:
$ 64.35万 - 项目类别:
A tethered capsule endoscopic-endomicroscopic (TEEM) approach for improving upper GI tract diagnosis
用于改善上消化道诊断的系留胶囊内镜-内镜 (TEEM) 方法
- 批准号:
10327702 - 财政年份:2019
- 资助金额:
$ 64.35万 - 项目类别:
A tethered capsule endoscopic-endomicroscopic (TEEM) approach for improving upper GI tract diagnosis
用于改善上消化道诊断的系留胶囊内镜-内镜 (TEEM) 方法
- 批准号:
10078943 - 财政年份:2019
- 资助金额:
$ 64.35万 - 项目类别:
Less invasive assessment of inflammation and subepithelial remodeling in eosinophilic esophagitis patients
嗜酸性粒细胞性食管炎患者炎症和上皮下重塑的微创评估
- 批准号:
9762923 - 财政年份:2018
- 资助金额:
$ 64.35万 - 项目类别:
Less invasive assessment of inflammation and subepithelial remodeling in eosinophilic esophagitis patients
嗜酸性粒细胞性食管炎患者炎症和上皮下重塑的微创评估
- 批准号:
10210260 - 财政年份:2018
- 资助金额:
$ 64.35万 - 项目类别:
Natural History of Barrett's Esophagus Using Capsule Endomicroscopy
使用胶囊内镜检查巴雷特食管的自然史
- 批准号:
9277434 - 财政年份:2014
- 资助金额:
$ 64.35万 - 项目类别:
Celiac Disease Diagnosis using Tethered Capsule Endomicroscopy
使用系留胶囊内镜检查进行乳糜泻诊断
- 批准号:
9097686 - 财政年份:2014
- 资助金额:
$ 64.35万 - 项目类别:
Celiac Disease Diagnosis using Tethered Capsule Endomicroscopy
使用系留胶囊内镜检查进行乳糜泻诊断
- 批准号:
8760911 - 财政年份:2014
- 资助金额:
$ 64.35万 - 项目类别:
Celiac Disease Diagnosis using Tethered Capsule Endomicroscopy
使用系留胶囊内镜检查进行乳糜泻诊断
- 批准号:
9518853 - 财政年份:2014
- 资助金额:
$ 64.35万 - 项目类别:
Transnasal Probe for Diagnosing Eosinophilic Esophagitis
用于诊断嗜酸性食管炎的经鼻探头
- 批准号:
8537448 - 财政年份:2011
- 资助金额:
$ 64.35万 - 项目类别:
相似海外基金
Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
- 批准号:
10887038 - 财政年份:2023
- 资助金额:
$ 64.35万 - 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
- 批准号:
10877239 - 财政年份:2023
- 资助金额:
$ 64.35万 - 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
- 批准号:
MR/X007979/1 - 财政年份:2023
- 资助金额:
$ 64.35万 - 项目类别:
Research Grant
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
- 批准号:
10735074 - 财政年份:2023
- 资助金额:
$ 64.35万 - 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
- 批准号:
10538074 - 财政年份:2022
- 资助金额:
$ 64.35万 - 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
- 批准号:
10537275 - 财政年份:2022
- 资助金额:
$ 64.35万 - 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
- 批准号:
10661533 - 财政年份:2022
- 资助金额:
$ 64.35万 - 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
- 批准号:
10467260 - 财政年份:2022
- 资助金额:
$ 64.35万 - 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
- 批准号:
10366610 - 财政年份:2022
- 资助金额:
$ 64.35万 - 项目类别:














{{item.name}}会员




